Abbott Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT
ABBOTT has one hundred and eleven approved drugs.
Summary for Abbott
| US Patents: | 0 |
| Tradenames: | 89 |
| Ingredients: | 62 |
| NDAs: | 111 |
| Patent Litigation for Abbott: | See patent lawsuits for Abbott |
Drugs and US Patents for Abbott
Expired US Patents for Abbott
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-003 | Dec 14, 1994 | 5,412,095 | ⤷ Start Trial |
| Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-003 | Dec 14, 1994 | 5,212,176 | ⤷ Start Trial |
| Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | 4,026,894 | ⤷ Start Trial |
| Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-002 | Dec 14, 1994 | 4,251,532 | ⤷ Start Trial |
| Abbott | PROSOM | estazolam | TABLET;ORAL | 019080-002 | Dec 26, 1990 | 3,987,052 | ⤷ Start Trial |
| Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-002 | Approved Prior to Jan 1, 1982 | 3,624,205 | ⤷ Start Trial |
| Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | 4,026,894 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
| ➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
| ➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
Similar Applicant Names
Here is a list of applicants with similar names.

